Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Nakajima

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Oncology|January 8, 2025
Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective StudyTomoki Higashiyama, Kozo Kuribayashi, Hiroshi Doi, et al.
Thoracic Cancer|March 11, 2025
Clinical Significance of Bone Metastases in Pleural MesotheliomaMitsutomi Miyake, Kozo Kuribayashi, Hiroshi Doi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 18, 2006
[High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report]Takahisa Yamane, Asao Hirose, Yasuhiro Nakajima, et al.
Journal of the American Geriatrics Society|September 29, 2004
An 85-year-old Japanese woman with Philadelphia chromosome-positive chronic myelogenous leukemia with del (5q) successfully treated by intermittent imatinib therapyToyoki Maeda, Toshitaka Mutoh, Hiromi Muta, et al.
Haematologica|June 15, 2004
Successful treatment of pure red cell aplasia with cyclosporin A and erythropoietin after thymectomy in a 88-year old womanToyoki Maeda, Satoshi Shiokawa, Yasuji Yoshikawa, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2023
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulationAkio Tada, Toshiyuki Minami, Hidemi Kitai, et al.
Biochemical and Biophysical Research Communications|September 28, 2019
EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrestHirotoshi Ishigaki, Toshiyuki Minami, Osamu Morimura, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 2004
Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary deathSanae Takeichi, Yasuhiro Nakajima, Nobuhiro Yukawa, et al.
Cancer Science|June 13, 2020
Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesotheliomaDaisuke Horio, Toshiyuki Minami, Hidemi Kitai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2005
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]Asao Hirose, Takahisa Yamane, Yasuhiro Nakajima, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Oncology|January 8, 2025
Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective StudyTomoki Higashiyama, Kozo Kuribayashi, Hiroshi Doi, et al.
Thoracic Cancer|March 11, 2025
Clinical Significance of Bone Metastases in Pleural MesotheliomaMitsutomi Miyake, Kozo Kuribayashi, Hiroshi Doi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 18, 2006
[High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report]Takahisa Yamane, Asao Hirose, Yasuhiro Nakajima, et al.
Journal of the American Geriatrics Society|September 29, 2004
An 85-year-old Japanese woman with Philadelphia chromosome-positive chronic myelogenous leukemia with del (5q) successfully treated by intermittent imatinib therapyToyoki Maeda, Toshitaka Mutoh, Hiromi Muta, et al.
Haematologica|June 15, 2004
Successful treatment of pure red cell aplasia with cyclosporin A and erythropoietin after thymectomy in a 88-year old womanToyoki Maeda, Satoshi Shiokawa, Yasuji Yoshikawa, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2023
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulationAkio Tada, Toshiyuki Minami, Hidemi Kitai, et al.
Biochemical and Biophysical Research Communications|September 28, 2019
EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrestHirotoshi Ishigaki, Toshiyuki Minami, Osamu Morimura, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 2004
Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary deathSanae Takeichi, Yasuhiro Nakajima, Nobuhiro Yukawa, et al.
Cancer Science|June 13, 2020
Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesotheliomaDaisuke Horio, Toshiyuki Minami, Hidemi Kitai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2005
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]Asao Hirose, Takahisa Yamane, Yasuhiro Nakajima, et al.
Pageof 8